Literature DB >> 28389622

IL-4Rα on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection.

Bishwas Shrestha1,2,3, Dahui You1,2, Jordy Saravia1,2, David T Siefker1,2, Sridhar Jaligama1,2, Greg I Lee1,2, Asmaa A Sallam1,2, Jeffrey N Harding1,2,3, Stephania A Cormier4,2,3.   

Abstract

Respiratory syncytial virus (RSV) is one of the leading causes of bronchiolitis in children, and severe RSV infection early in life has been associated with asthma development. Using a neonatal mouse model, we have shown that down-regulation of IL-4 receptor α (IL-4Rα) with antisense oligonucleotides in the lung during neonatal infection protected from RSV immunopathophysiology. Significant down-regulation of IL-4Rα was observed on pulmonary CD11b+ myeloid dendritic cells (mDCs) suggesting a role for IL-4Rα on mDCs in the immunopathogenesis of neonatal RSV infection. Here, we demonstrated that neonatal CD11b+ mDCs expressed higher levels of IL-4Rα than their adult counterparts. Because CD11b+ mDCs mainly present antigens to CD4+ T cells, we hypothesized that increased expression of IL-4Rα on neonatal CD11b+ mDCs was responsible for Th2 - biased RSV immunopathophysiology. Indeed, when IL-4Rα was selectively deleted from CD11b+ mDCs, the immunopathophysiology typically observed following RSV reinfection was ablated, including Th2 inflammation, airway-mucus hyperproduction, and pulmonary dysfunction. Further, overexpression of IL-4Rα on adult CD11b+ DCs and their adoptive transfer into adult mice was able to recapitulate the Th2-biased RSV immunopathology typically observed only in neonates infected with RSV. IL-4Rα levels on CD11c+ cells were inversely correlated with maturation status of CD11b+ mDCs upon RSV infection. Our data demonstrate that developmentally regulated IL-4Rα expression is critical for the maturity of pulmonary CD11b+ mDCs and the Th2-biased immunopathogenesis of neonatal RSV infection. © Society for Leukocyte Biology.

Entities:  

Keywords:  CD11b+ mDCs; RSV; immunopathogenesis

Mesh:

Substances:

Year:  2017        PMID: 28389622      PMCID: PMC5470835          DOI: 10.1189/jlb.4A1216-536R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  36 in total

1.  A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants.

Authors:  R Y Sung; S H Hui; C K Wong; C W Lam; J Yin
Journal:  Eur J Pediatr       Date:  2001-02       Impact factor: 3.183

2.  Methods for monitoring dynamics of pulmonary RSV replication by viral culture and by real-time reverse transcription-PCR in vivo: Detection of abortive viral replication.

Authors:  Marina S Boukhvalova; Kevin C Yim; Gregory A Prince; Jorge C G Blanco
Journal:  Curr Protoc Cell Biol       Date:  2010-03

3.  Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.

Authors:  Michael J Ripple; Dahui You; Srinivasa Honnegowda; Joseph D Giaimo; Andrew B Sewell; David M Becnel; Stephania A Cormier
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

4.  IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent.

Authors:  K K Tekkanat; H F Maassab; D S Cho; J J Lai; A John; A Berlin; M H Kaplan; N W Lukacs
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

Review 5.  Respiratory syncytial virus bronchiolitis: clinical aspects and epidemiology.

Authors:  K D Boeck
Journal:  Monaldi Arch Chest Dis       Date:  1996-06

6.  Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.

Authors:  Stephania A Cormier; Bishwas Shrestha; Jordy Saravia; Greg I Lee; Li Shen; John P DeVincenzo; Young-In Kim; Dahui You
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

7.  Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.

Authors:  Nele Sigurs; Fatma Aljassim; Bengt Kjellman; Paul D Robinson; Fridrik Sigurbergsson; Ragnar Bjarnason; Per M Gustafsson
Journal:  Thorax       Date:  2010-06-27       Impact factor: 9.139

Review 8.  The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors:  Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

9.  Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood.

Authors:  Fiona J Culley; Joanne Pollott; Peter J M Openshaw
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

10.  Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response.

Authors:  Tracy J Ruckwardt; Allison M W Malloy; Kaitlyn M Morabito; Barney S Graham
Journal:  PLoS Pathog       Date:  2014-02-13       Impact factor: 6.823

View more
  11 in total

Review 1.  Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus.

Authors:  Karen Bohmwald; Janyra A Espinoza; Raúl A Pulgar; Evelyn L Jara; Alexis M Kalergis
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

Review 2.  Pulmonary Susceptibility of Neonates to Respiratory Syncytial Virus Infection: A Problem of Innate Immunity?

Authors:  Carole Drajac; Daphné Laubreton; Sabine Riffault; Delphyne Descamps
Journal:  J Immunol Res       Date:  2017-11-09       Impact factor: 4.818

Review 3.  Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity.

Authors:  Diego R Hijano; Luan D Vu; Lawrence M Kauvar; Ralph A Tripp; Fernando P Polack; Stephania A Cormier
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

4.  Unbiased analysis of peripheral blood mononuclear cells reveals CD4 T cell response to RSV matrix protein.

Authors:  Juilee Thakar; Yu Qian; Lauren Benoodt; David Roumanes; Xing Qiu; Nathan Laniewski; ChinYi Chu; Christopher Slaunwhite; Lu Wang; Aishwarya Mandava; Ivan Chang; Ann R Falsey; Mary T Caserta; Thomas J Mariani; Richard H Scheuermann; Edward E Walsh; David J Topham
Journal:  Vaccine X       Date:  2020-04-21

5.  Systematic Identification and Analysis of Circular RNAs of Japanese Flounder (Paralichthys olivaceus) in Response to Vibrio anguillarum Infection.

Authors:  Xianhui Ning; Li Sun
Journal:  Genes (Basel)       Date:  2021-01-15       Impact factor: 4.096

6.  Current Insights in the Development of Efficacious Vaccines Against RSV.

Authors:  Jorge A Soto; Laura M Stephens; Kody A Waldstein; Gisela Canedo-Marroquín; Steven M Varga; Alexis M Kalergis
Journal:  Front Immunol       Date:  2020-07-17       Impact factor: 7.561

Review 7.  The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses.

Authors:  Jorge A Soto; Nicolas M S Gálvez; Catalina A Andrade; Gaspar A Pacheco; Karen Bohmwald; Roslye V Berrios; Susan M Bueno; Alexis M Kalergis
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

Review 8.  Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.

Authors:  Catalina A Andrade; Gaspar A Pacheco; Nicolas M S Gálvez; Jorge A Soto; Susan M Bueno; Alexis M Kalergis
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

Review 9.  Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells.

Authors:  Eduardo I Tognarelli; Susan M Bueno; Pablo A González
Journal:  Front Immunol       Date:  2019-04-15       Impact factor: 7.561

Review 10.  Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection.

Authors:  Hi Eun Jung; Tae Hoon Kim; Heung Kyu Lee
Journal:  Viruses       Date:  2020-01-15       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.